Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Malignant Melanoma

  Free Subscription


Articles published in Proc Natl Acad Sci U S A

Retrieve available abstracts of 23 articles:
HTML format



Single Articles


    June 2021
  1. ZHAO J, Jaffe A, Li H, Lindenbaum O, et al
    Detection of differentially abundant cell subpopulations in scRNA-seq data.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    April 2021
  2. FALAHAT R, Berglund A, Putney RM, Perez-Villarroel P, et al
    Epigenetic reprogramming of tumor cell-intrinsic STING function sculpts antigenicity and T cell recognition of melanoma.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    March 2021
  3. TENGESDAL IW, Menon DR, Osborne DG, Neff CP, et al
    Targeting tumor-derived NLRP3 reduces melanoma progression by limiting MDSCs expansion.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    February 2021
  4. ZHANG H, You X, Wang X, Cui L, et al
    Delivery of mRNA vaccine with a lipid-like material potentiates antitumor efficacy through Toll-like receptor 4 signaling.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    December 2020
  5. PATUTINA OA, Gaponova Miroshnichenko SK, Sen'kova AV, Savin IA, et al
    Mesyl phosphoramidate backbone modified antisense oligonucleotides targeting miR-21 with enhanced in vivo therapeutic potency.
    Proc Natl Acad Sci U S A. 2020;117:32370-32379.
    PubMed     Abstract available


  6. EISINGER S, Sarhan D, Boura VF, Ibarlucea-Benitez I, et al
    Targeting a scavenger receptor on tumor-associated macrophages activates tumor cell killing by natural killer cells.
    Proc Natl Acad Sci U S A. 2020;117:32005-32016.
    PubMed     Abstract available


    November 2020
  7. LU Y, Sandoval A, Voss S, Lai Z, et al
    Oncogenic allelic interaction in Xiphophorus highlights hybrid incompatibility.
    Proc Natl Acad Sci U S A. 2020;117:29786-29794.
    PubMed     Abstract available


    August 2020
  8. DEAN DN, Lee JC
    Defining an amyloid link Between Parkinson's disease and melanoma.
    Proc Natl Acad Sci U S A. 2020 Aug 31. pii: 2009702117.
    PubMed     Abstract available


  9. LI N, Kang Y, Wang L, Huff S, et al
    ALKBH5 regulates anti-PD-1 therapy response by modulating lactate and suppressive immune cell accumulation in tumor microenvironment.
    Proc Natl Acad Sci U S A. 2020;117:20159-20170.
    PubMed     Abstract available


    July 2020
  10. TAN J, Liu R, Zhu G, Umbricht CB, et al
    TERT promoter mutation determines apoptotic and therapeutic responses of BRAF-mutant cancers to BRAF and MEK inhibitors: Achilles Heel.
    Proc Natl Acad Sci U S A. 2020;117:15846-15851.
    PubMed     Abstract available


    June 2020
  11. LEX K, Maia Gil M, Lopes-Bastos B, Figueira M, et al
    Telomere shortening produces an inflammatory environment that increases tumor incidence in zebrafish.
    Proc Natl Acad Sci U S A. 2020;117:15066-15074.
    PubMed     Abstract available


    May 2020
  12. PYO A, Kim DY, Kim H, Lim D, et al
    Ultrasensitive detection of malignant melanoma using PET molecular imaging probes.
    Proc Natl Acad Sci U S A. 2020 May 21. pii: 1922313117.
    PubMed     Abstract available


    April 2020

  13. Correction for AbuHammad et al., Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma.
    Proc Natl Acad Sci U S A. 2020 Apr 20. pii: 2005945117.
    PubMed    


    March 2020
  14. NICOLET BP, Guislain A, van Alphen FPJ, Gomez-Eerland R, et al
    CD29 identifies IFN-gamma-producing human CD8(+) T cells with an increased cytotoxic potential.
    Proc Natl Acad Sci U S A. 2020;117:6686-6696.
    PubMed     Abstract available


  15. SHARMA S, Zhang T, Michowski W, Rebecca VW, et al
    Targeting the cyclin-dependent kinase 5 in metastatic melanoma.
    Proc Natl Acad Sci U S A. 2020 Mar 19. pii: 1912617117.
    PubMed     Abstract available


  16. HERMANS D, Gautam S, Garcia-Canaveras JC, Gromer D, et al
    Lactate dehydrogenase inhibition synergizes with IL-21 to promote CD8(+) T cell stemness and antitumor immunity.
    Proc Natl Acad Sci U S A. 2020;117:6047-6055.
    PubMed     Abstract available


    February 2020
  17. TZENG SY, Patel KK, Wilson DR, Meyer RA, et al
    In situ genetic engineering of tumors for long-lasting and systemic immunotherapy.
    Proc Natl Acad Sci U S A. 2020;117:4043-4052.
    PubMed     Abstract available


  18. MULLOKANDOV G, Vijayakumar G, Leon P, Henry C, et al
    High-complexity extracellular barcoding using a viral hemagglutinin.
    Proc Natl Acad Sci U S A. 2020;117:2767-2769.
    PubMed     Abstract available


    December 2019
  19. LEE CJ, An HJ, Kim SM, Yoo SM, et al
    FBXW7-mediated stability regulation of signal transducer and activator of transcription 2 in melanoma formation.
    Proc Natl Acad Sci U S A. 2019 Dec 16. pii: 1909879116.
    PubMed     Abstract available


    November 2019
  20. PREMI S, Han L, Mehta S, Knight J, et al
    Genomic sites hypersensitive to ultraviolet radiation.
    Proc Natl Acad Sci U S A. 2019 Nov 13. pii: 1907860116.
    PubMed     Abstract available


  21. LINETTE GP, Becker-Hapak M, Skidmore ZL, Baroja ML, et al
    Immunological ignorance is an enabling feature of the oligo-clonal T cell response to melanoma neoantigens.
    Proc Natl Acad Sci U S A. 2019 Nov 4. pii: 1906026116.
    PubMed     Abstract available


    August 2019
  22. WANG X, Sun R, Hao X, Lian ZX, et al
    IL-17 constrains natural killer cell activity by restraining IL-15-driven cell maturation via SOCS3.
    Proc Natl Acad Sci U S A. 2019;116:17409-17418.
    PubMed     Abstract available


  23. ZHANG Y, Fang C, Wang RE, Wang Y, et al
    A tumor-targeted immune checkpoint blocker.
    Proc Natl Acad Sci U S A. 2019;116:15889-15894.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: